Edwards Lifesciences Corporation (ETR:EWL)

Edwards Lifesciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3,141	3,045	1,132	769	862.8	1,183
Short-Term Investments	757.9	930.7	500.5	446.3	604	219.4
Cash & Short-Term Investments	3,899	3,976	1,633	1,215	1,467	1,403
Cash Growth	129.65%	143.50%	34.35%	-17.15%	4.58%	-7.54%
Accounts Receivable	669.2	609.1	771.5	643	582.2	514.6
Other Receivables	82.7	118.3	56.6	56.1	82.7	88.2
Receivables	751.9	727.4	828.1	699.1	664.9	602.8
Inventory	1,114	1,087	903.5	875.5	726.7	802.3
Prepaid Expenses	111.3	121	128.8	110	85.2	75.1
Restricted Cash	0.7	3.2	3.3	0.5	1.5	16.6
Other Current Assets	336.4	371.2	539.2	195.4	235.6	191.6
Total Current Assets	6,213	6,285	4,036	3,096	3,181	3,091
Property, Plant & Equipment	1,795	1,784	1,675	1,725	1,639	1,489
Long-Term Investments	277.9	307.9	583.9	1,239	1,834	801.6
Goodwill	1,779	1,777	1,145	1,164	1,168	1,173
Other Intangible Assets	1,175	1,177	399.4	285.2	323.6	331.4
Long-Term Deferred Tax Assets	1,028	992.1	749.4	484	246.7	230.9
Other Long-Term Assets	607.3	603.1	619.2	299.1	110.8	119.6
Total Assets	13,022	13,055	9,363	8,293	8,503	7,237
Accounts Payable	172.4	197.4	186.6	201.9	204.5	196.5
Accrued Expenses	624.3	790.4	667.2	593.1	643.4	516
Current Portion of Leases	23.7	23.4	22.9	25.5	25.5	27.2
Current Income Taxes Payable	297.4	286.6	52.7	50.6	30.6	18.6
Current Unearned Revenue	46.2	53.7	-	-	-	-
Other Current Liabilities	230.8	153.7	266	151.3	128.3	135.6
Total Current Liabilities	1,395	1,505	1,195	1,022	1,032	893.9
Long-Term Debt	597.8	597.7	597	596.3	595.7	595
Long-Term Leases	77.9	78.9	65.2	69.5	69.1	72.7
Other Long-Term Liabilities	760.2	778.5	750	774.1	928.6	1,048
Total Liabilities	2,831	2,992	2,644	2,486	2,667	2,663
Common Stock	655.9	654.8	650.5	646.3	642	636.4
Additional Paid-In Capital	2,653	2,613	2,274	1,969	1,700	1,438
Retained Earnings	13,525	13,167	8,992	7,590	6,068	4,565
Treasury Stock	-6,451	-6,192	-5,025	-4,144	-2,417	-1,904
Comprehensive Income & Other	-254.5	-244.5	-242.8	-254.9	-157.7	-161.1
Total Common Equity	10,129	9,998	6,650	5,807	5,836	4,574
Minority Interest	62.9	64.5	69.4	-	-	-
Shareholders' Equity	10,192	10,063	6,719	5,807	5,836	4,574
Total Liabilities & Equity	13,022	13,055	9,363	8,293	8,503	7,237
Total Debt	699.4	700	685.1	691.3	690.3	694.9
Net Cash (Debt)	3,205	3,281	947.7	524	776.5	707.7
Net Cash Growth	220.98%	246.25%	80.86%	-32.52%	9.72%	-15.56%
Net Cash Per Share	5.38	5.48	1.56	0.84	1.23	1.12
Filing Date Shares Outstanding	586.6	587.9	601.3	608.31	623.21	624.52
Total Common Shares Outstanding	586.2	588.6	601.1	608.3	624.1	624.3
Working Capital	4,818	4,780	2,840	2,073	2,148	2,197
Book Value Per Share	17.28	16.99	11.06	9.55	9.35	7.33
Tangible Book Value	7,175	7,045	5,106	4,357	4,344	3,070
Tangible Book Value Per Share	12.24	11.97	8.49	7.16	6.96	4.92
Land	-	123.9	112.4	116.3	116.5	97.6
Buildings	-	1,340	1,189	1,189	1,010	881.5
Machinery	-	689.4	618.6	735	652.6	607.1
Construction In Progress	-	244	292.5	255.2	333.8	313.3

Source: S&P Global Market Intelligence. Standard template. Financial Sources.